CTIS.eu › Cities › France › Paris
Paris
France
2,322 total trials
1,025 recruiting
Filter these 2,322 trials by phase, condition, sponsor and more.
Open in Search →
2024-519786-22-01
9
metastatic non-small cell lung cancer (NSCLC)
2024-519881-32-00
9
Sickle Cell Disease
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
2024-519986-23-00
5
The study will involve adult women and men from 16 French centers who
2024-520045-23-00
4
Kidney cancer
2024-520089-70-00
5
Cutaneous lupus erythematosus
2024-520125-36-00
3
Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloid Leukemia
2024-520140-42-00
5
Patients with primary HPV high-grade squamous intra-epithelial lesions
2024-520294-13-00
1
Cutaneous T-cell lymphomas (CTCL)
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
2025-520539-17-00
4
Austistic spectrum disorder
2025-520554-11-00
5
Cardiovascular Disease
2025-520573-39-00
6
Ultra High Risk of psychosis and first episode psychosis
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
2025-520783-17-01
4
Adult patients diagnosed with uncomplicated acute appendicitis
2025-520842-31-00
5
Population of study participants Pregnant women with PPROM at 22 to 33
2025-520940-14-00
6
Pyogenic liver abscess
2025-520946-31-00
1
Non-Small Cell Lung Cancer
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
2025-520995-24-00
5
Adult patients treated for haematological disorders, in whom chemother
2025-521090-14-00
4
Patients with relapsed/refractory symptomatic multiple myeloma (MM)
2025-521093-34-00
5
rare disease
2025-521113-13-00
10
Early Parkinson’s Disease
2025-521161-27-00
4
Children and adolescents with severe neurodevelopmental disorders
Showing 121–144 of 2,322 trials